Parkinsonism following neuroleptic withdrawal. 1989

A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg

UI MeSH Term Description Entries
D008297 Male Males
D010302 Parkinson Disease, Secondary Conditions which feature clinical manifestations resembling primary Parkinson disease that are caused by a known or suspected condition. Examples include parkinsonism caused by vascular injury, drugs, trauma, toxin exposure, neoplasms, infections and degenerative or hereditary conditions. Clinical features may include bradykinesia, rigidity, parkinsonian gait, and masked facies. In general, tremor is less prominent in secondary parkinsonism than in the primary form. (From Joynt, Clinical Neurology, 1998, Ch38, pp39-42) Atherosclerotic Parkinsonism,Secondary Parkinsonism,Symptomatic Parkinson Disease,Parkinson Disease, Secondary Vascular,Parkinson Disease, Symptomatic,Parkinsonism, Secondary,Parkinsonism, Symptomatic,Secondary Vascular Parkinson Disease,Parkinsonism, Atherosclerotic,Secondary Parkinson Disease,Symptomatic Parkinsonism
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013375 Substance Withdrawal Syndrome Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug. Drug Withdrawal Symptoms,Withdrawal Symptoms,Drug Withdrawal Symptom,Substance Withdrawal Syndromes,Symptom, Drug Withdrawal,Symptom, Withdrawal,Symptoms, Drug Withdrawal,Symptoms, Withdrawal,Syndrome, Substance Withdrawal,Syndromes, Substance Withdrawal,Withdrawal Symptom,Withdrawal Symptom, Drug,Withdrawal Symptoms, Drug,Withdrawal Syndrome, Substance,Withdrawal Syndromes, Substance
D014150 Antipsychotic Agents Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. Antipsychotic,Antipsychotic Agent,Antipsychotic Drug,Antipsychotic Medication,Major Tranquilizer,Neuroleptic,Neuroleptic Agent,Neuroleptic Drug,Neuroleptics,Tranquilizing Agents, Major,Antipsychotic Drugs,Antipsychotic Effect,Antipsychotic Effects,Antipsychotics,Major Tranquilizers,Neuroleptic Agents,Neuroleptic Drugs,Tranquillizing Agents, Major,Agent, Antipsychotic,Agent, Neuroleptic,Drug, Antipsychotic,Drug, Neuroleptic,Effect, Antipsychotic,Major Tranquilizing Agents,Major Tranquillizing Agents,Medication, Antipsychotic,Tranquilizer, Major

Related Publications

A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
April 1983, Annals of neurology,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
February 1996, Journal of neurology, neurosurgery, and psychiatry,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
September 1986, Meditsinskaia sestra,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
May 2015, Movement disorders : official journal of the Movement Disorder Society,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
January 1990, Revue neurologique,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
July 1992, Biological psychiatry,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
July 2018, Parkinsonism & related disorders,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
March 1991, Journal of the American Academy of Child and Adolescent Psychiatry,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
March 2006, Neurology,
A C Nelli, and P E Yarden, and M Guazzelli, and I Feinberg
January 1971, Psychiatria polska,
Copied contents to your clipboard!